1014
M. Bröring et al. / Journal of Organometallic Chemistry 694 (2009) 1011–1015
0.39 mmol) in CH2Cl2 (100 mL). Substituted benzaldehyde
(0.33 mmol) was added and the mixture was stirred at room tem-
perature for 4 h. The reaction mixture was diluted to 10 mL with
CH2Cl2 and slowly added to vigorously stirred CH2Cl2 (150 mL)
simultaneously with a solution of DDQ (195 mg, 0.86 mmol) in
THF (10 mL). The mixture was stirred for further 15 min and evap-
orated to dryness. The crude product was passed over a chroma-
tography column (silica, CH2Cl2/hexane, 4:1). The first, violet
band contained the corrole 2a contaminated with unreacted alde-
hyde. Dry column vacuum chromatography (DCVC) (silica, CH2 Cl2/
hexane, 3:1) of this mixture afforded the pure corrole.
(toluene)/nm 414 (
569 (16), 609 (9.5), 638 (3.6); 409 (97), 567.7 (15), 605.7 (9.7),
638 (5.2), 673 (1.5).
ꢀ
 10À3/dm3 molÀ1 cmÀ1 100), 430 (91),
4a: UV–Vis (CH2Cl2): kmax (lg
(2.95), 643sh (2.78) nm; 1H NMR (300 MHz, CD2Cl2): d = 9.14 (d,
J = 4.3 Hz, H, b-H), 8.79 (d, J = 4.8 Hz, 2H, b-H), 8.71 (d,
e) = 416 (4.99), 568 (3.20), 615
2
J = 4.8 Hz, 2H, b-H), 8.59 (d, J = 4.3 Hz, 2H, b-H), 8.41 (d, J = 8.3 Hz,
4H, meta-H), 7.80 (t, J = 8.3 Hz, 2H, para-H), 7.34 (s, 2H, ortho-H),
7.22 (s, 4H, NH), 4.06 (s, 3 H, para-OCH3), 3.93 (s, 6 H, meta-
OCH3), 0.18 (s, 36H, t-Bu-H); HRMS-ESI ([M+H]+): m/z: 1013.5282
(calcd for C60H69N8O7: 1013.5284).
2a (67.5 mg, 22%). UV–Vis (CH2Cl2): kmax
(
e
rel) = 411 (1.00), 427
5a: UV–Vis (CH2Cl2): kmax (erel) = 415 (1.00), 566 (0.16), 612
(0.79), 569 (0.16), 610 (0.10), 638 (0.05) nm; 1H NMR (300 MHz,
CD2Cl2): d = 9.04 (d, J = 4.2 Hz, 2H, b-H), 8.70 (d, J = 4.7 Hz, 2H, b-
H), 8.52 (d, J = 4.7 Hz, 2H, b-H), 8.41 (d, J = 4.2 Hz, 2H, b-H), 8.03
(d, J = 8.1 Hz, 4H, meta-H), 7.54 (t, J = 8.1 Hz, 2H, para-H), 7.44 (s,
2H, ortho-H), 4.06 (s, 3H, para-OCH3), 3.94 (s, 6H, meta-OCH3);
HRMS-ESI ([M+H]+): m/z: 932.8944 (calcd for C40H29Br4N4O3:
932.8927).
(0.10), 636sh (0.07) nm; 1H NMR (300 MHz, CD2Cl2): d = 9.13–
9.10 (m, 2H, b-H), 8.79–8.75 (m, 2H, b-H), 8.75–8.72 (m, 1H,
meta-H), 8.70–8.63 (m, 2H, b-H), 8.56–8.54 (m, 2H, b-H), 8.46–
8.41 (m, 2H, meta-H), 7.83–7.77 (m, 2H, meta-H + para-H), 7.69 (t,
J = 8.2 Hz, 1H, para-H), 7.42–7.33 (m, 2H, meta-H + NH), 7.31 (s,
1H, NH), 7.24 (s, 1H, NH), 4.06 (s, 3H, OCH3), 3.95 (s, 3H, OCH3),
3.92 (s, 3H, OCH3), 0.21 (s, 9H, t-Bu-H), 0.19 (s, 9 H, t-Bu-H), 0.14
(s, 9H, t-Bu-H); HRMS-ESI ([M+H]+): m/z: 992.3704 (calcd for
C55H59BrN7O6: 992.3705).
2b (50.7 mg, 18%). UV–Vis (CH2Cl2): kmax (erel) = 411 (1.00), 426
(0.77), 570 (0.14), 611 (0.09), 639 (0.05) nm; 1H NMR (300 MHz,
CD2Cl2): d = 9.04 (d, J = 4.2 Hz, 2H, b-H), 8.62 (d, J = 4.7 Hz, 2H, b-
H), 8.52 (d, J = 4.7 Hz, 2H, b-H), 8.41 (d, J =4.2 Hz, 2H, b-H), 8.07
(d, J = 7.9 Hz, 2H, Ph-H), 8.02 (d, J = 8.1 Hz, 4H, meta-H), 7.58–7.50
(m, 4H, Ph-H and para-H), 2.67 (s, 3H, CH 3); HRMS-ESI ([M+H]+):
m/z: 856.8761 (calcd for C38H25Br4N4: 856.8766).
6a: UV–Vis (CH2Cl2): kmax (erel) = 412 (1.00), 564 (0.15), 611
(0.09), 636 (0.06) nm; 1H NMR (300 MHz, CD2Cl2): d = 9.10 (d,
J = 4.3 Hz, 2H, b-H), 8.78-8.73 (m, 4H, b-H + meta-H), 8.63 (d,
J = 4.8 Hz, 2H, b-H), 8.50 (d, J = 4.3 Hz, 2H, b-H), 7.79 (dd,
J = 8.1 Hz, J = 1.2 Hz, 2H, meta-H), 7.68 (t, J = 8.2 Hz, 2H, para-H),
7.54 (d, J = 1.8 Hz, 1H, ortho-H), 7.49 (br s, 4H, NH), 7.30 (d,
J = 1.8 Hz, 1H, ortho-H), 4.06 (s, 3H, –OCH3), 3.98 (s, 3H, –OCH3),
3.91 (s, 3H, –OCH3), 0.17 (s, 18H, t-Bu-H); HRMS-ESI ([M+H]+):
m/z: 973.2106 (calcd for C50H49Br2N6O5: 973.2105).
2c (55.4 mg, 20%). UV–Vis (CH2Cl2): kmax (erel) = 410 (1.00), 425
(0.77), 570 (0.14), 610 (0.09), 639 (0.04) nm; 1H NMR (300 MHz,
CD2Cl2): d = 9.04 (d, J = 4.2 Hz, 2H, b-H), 8.59 (d, J = 4.7 Hz, 2H, b-
H), 8.53 (d, J = 4.7 Hz, 2H, b- H), 8.41 (d, J =4.2 Hz, 2H, b-H), 8.21–
8.17 (m, 2H, Ph-H), 8.03 (d, J = 8.1 Hz, 4H, meta-H), 7.77–7.72 (m,
3H, Ph-H), 7.53 (t, J = 8.1 Hz, 2H, para-H); HRMS-ESI ([M+H]+): m/
z: 842.8597 (calcd for C37H23Br4N4: 842.8610).
3.3.4. Preparation and analyses for 7
Under a blanket of Argon, corrole 4a (20 mg, 20
FeCl2 Â 4H2O (12 mg, 60 mol) are dissolved in 2 mL of metha-
nol/pyridine (2:1) and heated to reflux for 90 min. Saturated aque-
ous sodium nitrite (20 L) is then added and the mixture is heated
lmol) and
2d (59.9 mg, 21%). UV–Vis (CH2Cl2): kmax (erel) = 412 (1.00), 428
(0.81), 570 (0.15), 608 (0.09), 638 (0.03) nm; 1H NMR (300 MHz,
CD2Cl2): d = 9.04 (d, J = 4.2 Hz, 2H, b-H), 8.59 (d, J = 4.8 Hz, 2H, b-
H), 8.55 (d, J = 4.8 Hz, 2H, b-H), 8.44 (d, J = 4.2 Hz, 2H, b-H), 8.35
(d, J = 8.2 Hz, 2H, Ph-H), 8.05 (d, J = 8.2 Hz, 2H, Ph-H), 8.00 (d,
J = 8.1 Hz, 4H, meta-H), 7.49 (t, J = 8.1 Hz, 2H, para-H); HRMS-ESI
([M+H]+): m/z: 867.8583 (calcd for C38H22Br4N5: 867.8562).
l
l
for another 30 min. All volatiles are removed in vacuo and the res-
idue is subjected to column chromatography (neutral alumina II,
methyl-t-butylether). The product elutes in the first red band and
yields a dark red solid after removal of the solvent. Yield: 16 mg
2e (73.0 mg, 25%). UV–Vis (CH2Cl2): kmax (erel) = 411 (1.00),
423sh (0.89), 570 (0.22), 608 (0.12), 639 (0.04) nm; 1H NMR
(300 MHz, CD2Cl2): d = 9.06 (d, J = 4.2 Hz, 2H, b-H), 8.62–8.55 (m,
6H, b-H and Ph-H), 8.44 (d, J = 4.2 Hz, 2H, b-H), 8.40 (d, J =8.8 Hz,
2H, Ph-H), 8.04 (d, J = 8.1 Hz, 4H, meta-H), 7.55 (t, J = 8.1 Hz, 2H,
para-H); HRMS-ESI ([M+H]+): m/z: 887.8450 (calcd for
C37H22Br4N5O2: 887.8466).
(15
lmol, 75%).
7: UV–Vis (CH2Cl2): kmax
(erel) = 373 (1.00), 413 (0.85), 540
(0.24) nm; 1H NMR (300 MHz, CD2Cl2): d = 8.24 (dd, 4J = 0.9 Hz,
3J = 8.1 Hz, 2H, meta-H), 8.13 (d, 3J = 4.8 Hz, 2H, b-H), 8.12 (dd,
4J = 0.9 Hz, 3J = 8.1 Hz, 2H, meta-H), 7.73 (d, 3J = 4.5 Hz, 2H, b-H),
7.66 (d, 3J = 4.8 Hz, 2H, b-H), 7.64 (t, 3J = 8.4 Hz, 2H, para-H), 7.58
(d, 3J = 4.8 Hz, 2H, b-H), 7.38 (bs, 2H, NH), 7.15 (bs, 2H, NHNO),
6.99 (d, 3J = 1.8 Hz, 1H, ortho-H), 6.86 (d, 3J = 1.8 Hz, 1H, ortho-H),
3.93 (s, 3H, para-OCH3), 3.90 (s, 3H, meta-OCH3), 3.81 (s, 3H,
meta-OCH3), 0.78 (s, 18 H, t-BuH), 0.50 (s, 18H, t-BuHNO); 13C
NMR (75 MHz, CD2Cl2): d = 176.1, 175.9, 153.3 (2C), 148.5, 147.2,
146.9, 138.5, 137.3 (4C), 134.0, 133.7, 130.1, 127.4 (2C), 125.9
(2C),125.5 (2C), 121.0, 120.2 (2C), 118.9 (2C), 118.0 (2C), 117.7
(2C), 107.7 (2C), 60.7, 56.3, 56.2, 39.4 (2C), 39.2 (2C), 26.9 (6C),
3.3.3. General procedure for the palladium-catalyzed amidation of
bromo-arylcorroles described for 4a/5a/6a
Corrole 2a (50 mg, 53.6
lmol), pivalinamide 3a (202 mg,
2 mmol), Pd(OAc)2 (1.25 mg, 5.5
lmol), Xantphos (7.5 mg,
12 mmol), and Cs2CO3 (325 mg, 1 mmol) were placed in an oven-
dried resealable Schlenk tube under an argon atmosphere. The
tube was sealed with a Teflon screwcap, evacuated and backfilled
with argon. THF (5 mL) was added via syringe. The tube was sealed
again with the Teflon screwcap and its contents were heated with
stirring. After 65 h at 125 °C, the mixture was cooled to room tem-
perature, taken up in ethyl acetate and concentrated in vacuo. The
crude product was purified by column chromatography (silica,
EtOAc/CH2Cl2, 1:9, then 1:4, then 2:5). Careful chromatography
yielded pure corroles 6aa (21.5 mg, 41%) and 5aa (6.9 mg, 13%)
from the first and second violet band, respectively. The third violet
fraction contained corrole 4aa contaminated with unidentified
products. Pure corrole 4aa was obtained by subsequent DCVC (sil-
ica, EtOAc/CH2Cl2, 5:2) as a purple solid (16.3 mg, 30%).
26.4 (6 C); IR (nujol):
m mNO), 1690 (amide),
(cmÀ1) = 3429, 1776 (
1582, 1500 (amide), 1348, 1296, 1261, 1127, 1055, 1017, 798;
HRMS-ESI ([MÀNO+H]+): m/z: 1066.4398 (calcd for C60H66N8O7Fe:
1066.4417); Anal. calc. (C60H65N9O8Fe): C, 65.75; H, 5.98; N, 11.50.
Found: C, 65.52; H, 5.88; N, 11.35%.
Acknowledgement
Financial support for this work by the Deutsche Forschungs-
gemeinschaft (DFG) is gratefully acknowledged.